GLP-1 / GIP Dual Agonist (T-GLP-1) 10MG
39-amino-acid synthetic dual agonist activating GLP-1 and GIP receptors. Enhances glucose-dependent insulin secretion, suppresses appetite, improves insulin sensitivity, and accelerates triglyceride clearance. Superior efficacy in weight loss and glycemic control vs. semaglutide, with better gastrointestinal tolerability. Weekly subcutaneous administration (2.5–15 mg), progressive titration. Research grade, 98%+ purity.
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
70%